U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
IB-367, a synthetic analog of porcine protegrin, is an antimicrobial peptide. It reduces the local microflora densities and may improve clinical outcomes in patients at risk for the development of oral mucositis.

Approval Year

PubMed

PubMed

TitleDatePubMed
The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial.
2012-03
Evaluation of pain associated with oral mucositis during the acute period after administration of high-dose chemotherapy.
2003-07-15
IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis.
2000-07
Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters.
1999-05

Sample Use Guides

The minimal inhibitory concentrations (MICs) of iseganan (IB-367) ranged from 0.13 to 64 microgram/ml for gram-positive bacteria (Streptococcus mitis, Streptococcus sanguis, Streptococcus salivarius, and Staphylococcus aureus) and from 0.06 to 8 microgram/ml for gram-negative species (Klebsiella, Escherichia, and Pseudomonas). IB-367 exhibited rapid, microbicidal activity against both log- and stationary-phase cultures of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. At concentrations near the MICs for these two organisms (4 and 2 microgram/ml, respectively), IB-367 reduced viability by more than 3 logs in less than 16 min. Similarly, IB-367 effected a 4-log reduction of the endogenous microflora in pooled human saliva within 2 min at 250 microgram/ml, a concentration readily attained by local delivery.
Substance Class Protein
Created
by admin
on Mon Mar 31 21:26:55 GMT 2025
Edited
by admin
on Mon Mar 31 21:26:55 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
HFF9H8LHP0
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IB-367-03
Preferred Name English
ISEGANAN HYDROCHLORIDE ANHYDROUS
Common Name English
L-ARGININAMIDE, L-ARGINYLGLYCYLGLYCYL-L-LEUCYL-L-CYSTEINYL-L-TYROSYL-L-CYSTEINYL-L-ARGINYLGLYCYL-L-ARGINYL-L-PHENYLALANYL-L-CYSTEINYL-L-VALYL-L-CYSTEINYL-L-VALYLGLYCYL-, CYCLIC (5->14), (7->12)-BIS(DISULFIDE), HYDROCHLORIDE
Common Name English
ARG-GLY-GLY-LEU-CYS-TYR-CYS-ARG-GLY-ARG-PHE-CYS-VAL-CYS-VAL-GLY-ARG-NH2, CYCLIC (5-14, 7-12) DISULFIDE HYDROCHLORIDE
Common Name English
ISEGANAN HYDROCHLORIDE [MI]
Common Name English
Iseganan hydrochloride [WHO-DD]
Common Name English
Code System Code Type Description
CAS
256475-21-5
Created by admin on Mon Mar 31 21:26:55 GMT 2025 , Edited by admin on Mon Mar 31 21:26:55 GMT 2025
PRIMARY
MERCK INDEX
m6420
Created by admin on Mon Mar 31 21:26:55 GMT 2025 , Edited by admin on Mon Mar 31 21:26:55 GMT 2025
PRIMARY Merck Index
FDA UNII
HFF9H8LHP0
Created by admin on Mon Mar 31 21:26:55 GMT 2025 , Edited by admin on Mon Mar 31 21:26:55 GMT 2025
PRIMARY
PUBCHEM
70691416
Created by admin on Mon Mar 31 21:26:55 GMT 2025 , Edited by admin on Mon Mar 31 21:26:55 GMT 2025
PRIMARY
EPA CompTox
DTXSID60180337
Created by admin on Mon Mar 31 21:26:55 GMT 2025 , Edited by admin on Mon Mar 31 21:26:55 GMT 2025
PRIMARY
From To
1_5 1_14
1_7 1_12
Related Record Type Details
STARTING MATERIAL -> INGREDIENT
Related Record Type Details
ACTIVE MOIETY

Agent Modifications

Modification Process Modification Role Modification Type Amount Fragment Name Fragment ID
AMINE SALT FORMATION CHEMICAL Hydrochloric Acid QTT17582CB

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
C-TERMINAL AMIDE [1_17] R ARGININAMIDE, L- 29626ZE0WY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:CALCULATED ANHYDROUS CHEMICAL
Molecular Formula CHEMICAL